Chinese Journal of Antituberculosis ›› 2023, Vol. 45 ›› Issue (2): 144-150.doi: 10.19982/j.issn.1000-6621.20220443
• Original Articles • Previous Articles Next Articles
Tian Lili1, Chen Shuangshuang1, Fan Ruifang1, Zhang Jie1, Wang Nenhan1, Chen Hao1, Dai Xiaowei1, Ren Yixuan1, Zhao Yanfeng1, Li Chuanyou1, Ding Beichuan1, Li Bo2, Yu Lan1, Yi Junli1, Wang Pei3, Yang Xinyu1(), Song Weiping3(
)
Received:
2022-11-07
Online:
2023-02-10
Published:
2023-02-01
Contact:
Yang Xinyu,Song Weiping
E-mail:6666yxy@sina.com;swp-8857@sina.com
Supported by:
CLC Number:
Tian Lili, Chen Shuangshuang, Fan Ruifang, Zhang Jie, Wang Nenhan, Chen Hao, Dai Xiaowei, Ren Yixuan, Zhao Yanfeng, Li Chuanyou, Ding Beichuan, Li Bo, Yu Lan, Yi Junli, Wang Pei, Yang Xinyu, Song Weiping. Clinical diagnostic value of combining four methods in detecting etiologically negative pulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 144-150. doi: 10.19982/j.issn.1000-6621.20220443
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20220443
检测方法 | 临床诊断 | 敏感度 (%) | 特异度 (%) | 阳性预测值 (%) | 阴性预测值 (%) | 准确度 (%) | |
---|---|---|---|---|---|---|---|
病原学阴性肺结 核例数(216例) | 其他肺部疾病 例数(455例) | ||||||
T-SPOT.TB | 82.4 | 71.4 | 57.8 | 89.5 | 75.0 | ||
阳性 | 178 | 130 | |||||
阴性 | 38 | 325 | |||||
TB-Ab | 39.8 | 81.1 | 50.0 | 74.1 | 73.9 | ||
阳性 | 86 | 86 | |||||
阴性 | 130 | 369 | |||||
ESR | 22.7 | 92.5 | 59.0 | 71.6 | 70.0 | ||
阳性 | 49 | 34 | |||||
阴性 | 167 | 421 | |||||
hs-CRP | 13.0 | 94.7 | 53.9 | 69.6 | 68.4 | ||
阳性 | 28 | 24 | |||||
阴性 | 188 | 431 | |||||
联合检测(4种) | 91.7 | 53.4 | 48.3 | 93.1 | 65.7 | ||
阳性 | 198 | 212 | |||||
阴性 | 18 | 243 |
联合检测 | 含T-SPOT.TB | 不含T-SPOT.TB | χ2值 | P值 | ||
---|---|---|---|---|---|---|
阳性例数 | 阳性率(%) | 阴性例数 | 阴性率(%) | |||
TB-Ab | 194 | 89.8 | 86 | 39.8 | 118.394 | 0.000 |
ESR | 183 | 84.7 | 49 | 22.7 | 167.177 | 0.000 |
hs-CRP | 180 | 83.3 | 28 | 13.0 | 214.220 | 0.000 |
TB-Ab+ESR | 196 | 90.7 | 99 | 45.8 | 100.574 | 0.000 |
TB-Ab+CRP | 196 | 90.7 | 99 | 45.8 | 100.574 | 0.000 |
ESR+hs-CRP | 185 | 85.7 | 60 | 27.8 | 147.332 | 0.000 |
TB-Ab+ESR+hs-CRP | 198 | 91.7 | 108 | 50.0 | 90.756 | 0.000 |
[1] | World Health Organization. Global tuberculosis report 2022. Geneva: World Health 0rganization, 2022. |
[2] | 中国结核网. 中国疾病预防控制中心结核病预防控制中心. 《2022年全球结核病报告》精解述评系列(二)全球和我国结核病诊断情况.[2022-11-30]. https://tb.chinacdc.cn/xxjlg/202211/t20221130_262820.htm. |
[3] |
《中国防痨杂志》编辑委员会, 中国医疗保健国际交流促进会结核病防治分会基础学组和临床学组. 现阶段结核抗体检测在我国临床应用的专家共识. 中国防痨杂志, 2018, 40(1): 9-13. doi:10.3969/j.issn.1000-6621.2018.01.004.
doi: 10.3969/j.issn.1000-6621.2018.01.004 |
[4] |
高孟秋. 《WS 288—2017肺结核诊断》新标准中关于临床诊断患者判定的解析. 中国防痨杂志, 2018, 40(3): 243-246.doi:10.3969/j.issn.1000-6621.2018.03.005.
doi: 10.3969/j.issn.1000-6621.2018.03.005 |
[5] |
张雨相, 熊将军. T-SPOT.TB、痰涂片和TB-DNA在检测肺结核诊断中的比较研究. 当代医学, 2015(28): 55-56. doi:10.3969/j.issn.1009-4393.2015.28.038.
doi: 10.3969/j.issn.1009-4393.2015.28.038 |
[6] |
田丽丽, 杨新宇, 代小伟, 等. 免疫学检测联合痰涂片和痰培养检测在活动性肺结核临床诊断中的价值. 中国防痨杂志, 2021, 43(10): 1073-1078. doi:10.3969/j.issn.1000-6621.2021.10.017.
doi: 10.3969/j.issn.1000-6621.2021.10.017 |
[7] |
杨春龙, 周林, 陈明亭. 《病原学检测阴性肺结核诊断流程(T/CHATA 008-2020)》解读. 中国防痨杂志, 2021, 43(11): 1116-1119. doi:10.3969/j.issn.1000-6621.2021.11.003.
doi: 10.3969/j.issn.1000-6621.2021.11.003 |
[8] |
季秋平. CRP、结核抗体检测应用于TB合并艾滋病中的临床价值分析. 临床医学工程, 2017, 24(1): 95-96. doi:10.3969/j.issn.1674-4659.2017.01.0095.
doi: 10.3969/j.issn.1674-4659.2017.01.0095 |
[9] |
巫红晋, 赵青艾, 赵利伟. 血清降钙素原和C-反应蛋白检测在肺结核合并肺部细菌感染中的临床意义. 吉林医学, 2021, 42(7): 1705-1706. doi:10.3969/j.issn.1004-0412.2021.07.065.
doi: 10.3969/j.issn.1004-0412.2021.07.065 |
[10] |
朱捷, 赵妮娜, 华彦珺, 等. 应用ROC曲线分析超敏C反应蛋白对肺结核活动性的诊断效能. 江苏预防医学, 2021, 32(5): 534-536. doi:10.13668/j.issn.1006-9070.2021.05.006.
doi: 10.13668/j.issn.1006-9070.2021.05.006 |
[11] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 2017-11-09. |
[12] | 中华人民共和国国家卫生和计划生育委员会. WS 196—2017结核病分类. 2017-11-09. |
[13] | 葛均波, 徐永健, 王辰. 内科学. 9版. 北京: 人民卫生出版社, 2018:8-155. |
[14] |
Yu SN, Jung J, Kim YK, et al. Diagnostic Usefulness of IFN-Gamma Releasing Assays Compared With Conventional Tests in Patients With Disseminated Tuberculosis. Medicine (Baltimore), 2015, 94(28): e1094. doi:10.1097/MD.0000000000001094.
doi: 10.1097/MD.0000000000001094 URL |
[15] |
蒋瑜, 吴婷. 结核感染T细胞斑点试验及抗结核抗体检测在结核诊断中的应用价值评. 国际检验医学杂志, 2017, 38(16): 2234-2236. doi:10.3969/j.issn.1673-4130.2017.16.022.
doi: 10.3969/j.issn.1673-4130.2017.16.022 |
[16] |
符艳, 蒋正华. 结核免疫斑点试验与结核菌素试验在活动性结核病诊断中的优越性对比. 中国医刊, 2015(8): 54-57. doi:10.3969/j.issn.1008-1070.2015.08.018.
doi: 10.3969/j.issn.1008-1070.2015.08.018 |
[17] |
刘裔, 韩红洋. 联合检测T-SPOT.TB、PPD 及TB-Ab 在活动性肺结核中的临床意义. 川北医学院学报, 2020, 35(5): 907-910. doi:10.3969/j.issn.1005-3697.2020.05.40.
doi: 10.3969/j.issn.1005-3697.2020.05.40 |
[18] |
陈振华, 刘彬彬, 陈忠南, 等. 病原学阴性初治肺结核患者诊断模型的建立及初步评价. 中国防痨杂志, 2020, 42(3): 266-271. doi:10.3969/j.issn.1000-6621.2020.03.016.
doi: 10.3969/j.issn.1000-6621.2020.03.016 |
[19] |
Ji L, Lou YL, Wu ZX, et al. Usefulness of interferon-γ release assay for the diagnosis of sputum smear-negative pulmonary and extra-pulmonary TB in Zhejiang Province, China. Infect Dis Poverty, 2017, 6(1): 121. doi:10.1186/s40249-017-0331-1.
doi: 10.1186/s40249-017-0331-1 pmid: 28859694 |
[20] |
杨蕾, 曹俊, 卢锦标, 等. 血清学抗体检测菌阴肺结核存在的问题讨论. 中华微生物学和免疫学杂志, 2017, 37(10): 785-789. doi:10.3760/cma.j.issn.0254-5101.2017.10.011.
doi: 10.3760/cma.j.issn.0254-5101.2017.10.011 |
[21] |
徐江涛. T-SPOT.TB与TB-Ab联合诊断菌阴肺结核的效果比较. 中国民康医学, 2019, 31(5): 130-132. doi:10.3969/j.issn.1672-0369.2019.05.058.
doi: 10.3969/j.issn.1672-0369.2019.05.058 |
[22] |
Ai L, Feng P, Chen D, et al. Clinical value of interferon-γ release assay in the diagnosis of active tuberculosis. Exp Ther Med, 2019, 18(2): 1253-1257. Epub 2019 Jun 21. doi:10.3892/etm.2019.7696.
doi: 10.3892/etm.2019.7696 pmid: 31363369 |
[23] |
孔海芳, 岳娜, 刘刚, 等. 全血γ干扰素释放试验诊断结核病的临床应用价值. 天津医药, 2016, 44(9): 1132-1135. doi:10.11958/20160397.
doi: 10.11958/20160397 |
[24] |
Maekura R, Kitada S, Osada-Oka M, et al. Serum antibody profiles in individuals with latent Mycobacterium tuberculosis infection. Microbiol Immunol, 2019, 63(3-4): 130-138. Epub 2019 Apr 9. doi:10.1111/1348-0421.12674.
doi: 10.1111/1348-0421.12674 pmid: 30851131 |
[25] |
杨珊明, 周建芳. 多指标联合检测同时阳性对菌阴肺结核的诊断价值. 中国预防医学杂志, 2007, 8(3): 275-277. doi:10.3969/j.issn.1009-6639.2007.03.037.
doi: 10.3969/j.issn.1009-6639.2007.03.037 |
[26] |
张俊仙, 阳幼荣, 王杰, 等. 结核分枝杆菌IgG和IgM抗体检测试剂临床应用价值的研究. 中国防痨杂志, 2018, 40(1): 53-57. doi:10.3969/j.issn.1000-6621.2018.01.013.
doi: 10.3969/j.issn.1000-6621.2018.01.013 |
[27] |
马龙凤. 对活动性肺结核患者采取超敏C反应蛋白及血沉检测的意义研究. 中国实用医药, 2021, 16(7): 70-72. doi:10.14163/j.cnki.11-5547/r.2021.07.028.
doi: 10.14163/j.cnki.11-5547/r.2021.07.028 |
[28] |
苏俊梅, 谢荣章, 欧雅文. TB-DNA、IgG、IgM及血沉检测在菌阴肺结核诊断中的应用价值探讨. 中国实用医药, 2021, 16(21): 69-71. doi:10.14163/j.cnki.11-5547/r.2021.21.025.
doi: 10.14163/j.cnki.11-5547/r.2021.21.025 |
[29] | 李曙光, 李莉, 张修磊. 酶联免疫斑点试验在菌(涂)阴肺结核辅助诊断中的价值-Meta分析. 现代预防医学, 2017, 44(3): 515-519. |
[1] | Song Hongge, Liu Weigao, Chen Li. A comparative study on the therapeutic effects of total hip joint type spacer and pressure model spacer in patients with mid to late stage hip tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(5): 562-566. |
[2] | Li Ting, Liu Shuang, Wang Danxia, Lu Jia, Cheng Qianqian, Chen Chuang, He Jin’ge, Zhang Linglin, Xia Yong, Li Jing, Zhang Shu, Gao Wenfeng, Xia Lan. Evaluation of health economics of implementation of tuberculosis prevention and control program in Sichuan Province from 2011 to 2020 [J]. Chinese Journal of Antituberculosis, 2024, 46(3): 333-339. |
[3] | Gulina Badeerhan, Liu Nianqiang, Yipaer Aihaiti, Wang Le, Wang Senlu, Zulikatiayi Abudula, Wang Mingzhe, Zhang Jing, Wang Xinqi, Bi Hongbo. The effect of GeneXpert MTB/RIF detection technology in tuberculosis prevention and control program in Xinjiang [J]. Chinese Journal of Antituberculosis, 2024, 46(2): 173-177. |
[4] | Li Jianghong, Liu Fang, Yang Shumin, He Yujue, Ma Ling, Guo Qiang, Man Shijun. Investigation and analysis of diagnostic quality of pathogenic negative pulmonary tuberculosis in county level tuberculosis designated hospitals in Gansu Province [J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1478-1484. |
[5] | Liu Shuren, Fu Lin, Wang Lianbo, Zhao Guisong, Li Zhuo, Dong Zhaoliang. Application of blood management in the perioperative period of lumbar tuberculosis under the concept of enhanced recovery after surgery [J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1343-1349. |
[6] | Zhao Guolian, Lei Qian, Wang Pei, Ren Yunxia, Guan Jing. Value of DNA real-time fluorescence isothermal amplification method and combined testing in early diagnosis of tuberculous pleurisy [J]. Chinese Journal of Antituberculosis, 2023, 45(7): 681-686. |
[7] | Song Ruixue, Wei Rongrong, Dong Jing, Jia Hongyan, Du Boping, Sun Qi, Xing Aiying, Li Zihui, Zhu Chuanzhi, Zhang Zongde, Pan Liping. The performance of interferon gamma-induced protein 10 mRNA detection technology in auxiliary diagnosis of tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(5): 471-476. |
[8] | Yan Xiaojing, Wang Qingfeng, Yang Yang, Chu Naihui, Nie Wenjuan. Diagnostic value of a nanopore sequencing assay of bronchoalveolar lavage fluid in smear-negative pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(5): 487-492. |
[9] | Liu Yueyuan, Su Wei, Zheng Jiangang, Wang Meng, Zeng Zhong, Huang Qin, Xie Tian, Li Renzhong. Study on the role of the prefectural tuberculosis designated hospital to improve the case finding of pulmonary tuberculosis in economic undeveloped areas of Jiangxi Province [J]. Chinese Journal of Antituberculosis, 2023, 45(3): 279-284. |
[10] | Yao Liming, Yao Xiaowei, Dong Zhaoliang, Liu Fengsheng, Wang Lianbo, Jia Chenguang. Diagnostic value of metagenomic next-generation sequencing in hip or knee tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(3): 292-296. |
[11] | Zhao Ailan, Yu Qin, Yu Nan, Zhang Aijie, Xia Hui, Xu Wei. The value of GeneXpert MTB/RIF in improving the laboratory confirmed pulmonary tuberculosis and rifampicin resistance screening at district level institution in Beijing [J]. Chinese Journal of Antituberculosis, 2023, 45(11): 1064-1071. |
[12] | Ruan Yunzhou, Zhang Hongwei, Li Yuehua, Ma Yingzi, Cheng Shiming, Fan Haiying, Li Renzhong, Zhao Yanlin. Analysis of the effect of GeneXpert MTB/RIF technology on early detection of bacteriologically confirmed and drug-resistant pulmonary tuberculosis in general hospitals [J]. Chinese Journal of Antituberculosis, 2023, 45(11): 1072-1077. |
[13] | Xu Yinjuan, Zhao Guolian, Cui Xiaoli, Dang Liyun, Kang Lei, Zhou Yong. The application value of SAT-TB in monitoring the curative effect of patients with tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(1): 79-84. |
[14] | Zhang Yun, Li Kun, Liang Qingtao, Liu Zichen, Duan Hongfei, Li Xuelian, Guo Ru, Che Nanying, Yang Xinting. The diagnostic value of cell-free Mycobacterium tuberculosis DNA test on pleural effusion in early diagnosis of tuberculous pleurisy [J]. Chinese Journal of Antituberculosis, 2022, 44(8): 835-843. |
[15] | Jiang Shuping, Liu Changwei, Li Bin, Xu Xiaoqin, Luo Wenji, Yu Bolin, Zhang Yue. Evaluation of the potential of cross-priming amplification for the diagnosis of Mycobacterium tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2022, 44(8): 844-848. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||